Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma of Skin AJCC V6”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004250
What this trial is testing

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)Sarcoma
Memorial Sloan Kettering Cancer Center 35
Large-scale testing (Phase 3)UnknownNCT00002763
What this trial is testing

High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 1,000
Large-scale testing (Phase 3)Study completedNCT00003444
What this trial is testing

Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 167
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Testing effectiveness (Phase 2)Looking for participantsNCT03842943
What this trial is testing

Neoadjuvant Combination Immunotherapy for Stage III Melanoma

Who this might be right for
Cutaneous Melanoma
University of Louisville 28
Testing effectiveness (Phase 2)Study completedNCT00020358
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT00006035
What this trial is testing

Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT04133948
What this trial is testing

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 44
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00004184
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Alabama at Birmingham 50
Not applicableStudy completedNCT00897520
What this trial is testing

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 40
Testing effectiveness (Phase 2)Study completedNCT00060333
What this trial is testing

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma

Who this might be right for
Recurrent Melanoma
Alliance for Clinical Trials in Oncology 20
Early research (Phase 1)Not Yet RecruitingNCT07581509
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

Who this might be right for
Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings)
Biocon Biologics UK PLC 138
Testing effectiveness (Phase 2)Ended earlyNCT00512798
What this trial is testing

Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma

Who this might be right for
Brain and Central Nervous System TumorsMelanomaSolid Tumor
Vanderbilt-Ingram Cancer Center 47
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00027742
What this trial is testing

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04303169
What this trial is testing

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 146
Testing effectiveness (Phase 2)Study completedNCT00243529
What this trial is testing

Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 64
Testing effectiveness (Phase 2)Ended earlyNCT05764395
What this trial is testing

Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+2 more
Vanderbilt-Ingram Cancer Center 7
Early research (Phase 1)Ended earlyNCT00005841
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 15
Next Page